Understanding the structural basis of replication initiation in AAV
了解 AAV 复制起始的结构基础
基本信息
- 批准号:8741430
- 负责人:
- 金额:$ 40.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Active SitesAmyotrophic Lateral SclerosisBindingBinding SitesBovine papillomavirus E1 proteinCellsCharacteristicsChildhoodChromosomes, Human, Pair 19Cleaved cellComplexCrystallizationCystic FibrosisDNADNA IntegrationDNA SequenceDNA biosynthesisDNA-dependent ATPase-endonucleaseDependovirusDiabetes MellitusDiseaseDisease remissionElectron MicroscopyEnzymesExhibitsFoundationsGene Transduction AgentGenesGenomeGoalsHemophilia AHumanHuman ChromosomesInsulinIonsLeadLightLocationMediatingMedicalMembrane ProteinsMetalsModelingMolecularMusNatureNucleotidesOligonucleotidesParvovirusProcessPropertyProteinsRattusReplication InitiationReplication-Associated ProcessReportingResearchResolutionSV40 T AntigensShorthandSickle Cell AnemiaSingle-Stranded DNASiteSpecificityStructureSurfaceSystemTetranucleotide RepeatTimeTyrosineViralViral GenomeViral ProteinsVirusanalogbasedesignendonucleasegene correctiongene therapyhelicasehuman DNAhuman diseaseimprovedinterestmembernucleasepreventprogramssite-specific integrationstructural biologysuccessvectorviral DNA
项目摘要
The structure of the Rep endonuclease domain (Hickman et al., 2002) revealed that it is unrelated to all other structurally characterized nucleases and provided the first view of an HUH superfamily member. Rep is homologous to the origin binding domains of the SV40 T antigen (Luo et al., 1996) and replication initiation protein E1 of bovine papillomavirus (Enemark et al., 2000). The HUH residues, which bind the catalytically required metal ion, converge with a helix bearing the two active site tyrosine residues to create the enzyme active site cleft. Subsequent co-crystal structures of the Rep nuclease domain with oligonucleotides representing two specific regions of the AAV genome showed that the nuclease domain uses two different protein surfaces to recognize its DNA target. One surface binds a hairpin that is at the very tip of the viral genome and the other recognizes a repeated tetranucleotide sequence close to the genome ends that constitutes the Rep binding site. These structures allowed us to propose a model for the assembly of a hexameric Rep-DNA complex that is poised to nick the viral DNA and begin unwinding it as a prelude to replication. It seems likely that site-specific integration also begins with a nick at a related sequence in human chromosome 19.
Although it is believed that Rep assembles as a hexameric helicase, such assemblies had not previously been observed and the mode of Rep multimerization remains controversal. We have recently been studying an N-terminally truncated version of Rep in which the endonuclease domain is missing. This portion of Rep assembles as a hexamer on both single-stranded and dsDNA substrates, and is not dependent on specific viral DNA sequences or on the presence of nucleotides. We identified the portion of the protein responsible for multimerization on DNA, and we have been able to directly visualize these hexameric complexes using electron microscopy. Crystallization trials are underway.
Enemark, E.J., Chen, G., Vaughn, D.E., Stenlund, A., and Joshua-Tor, L. (2000) Mol. Cell 6, 149-158.
Flotte, T.R. (2005) Pediatric Res. 58, 1143-1147.
Hickman, A.B., Ronning, D.R., Kotin, R.M., and Dyda, F. (2002) Mol. Cell 10, 327-337.
Im, D.S. and Muzyczka, N. (1990) Cell 61, 447-457.
Le Bec, C. and Douar, A.M. (2006) Gene Ther. 13, 805-813.
Lee, H.C., Kim, S.J., Kim, K.S., Shin, H.CV., and Yoon, J. W. (2000) Nature 408, 483-488.
Luo, X., Sanford, D.G., Bullock, P.A., and Bachovchin, W.W. (1996) Nat. Struct. Biol. 3, 1034-1039.
Rep 核酸内切酶结构域的结构(Hickman 等人,2002)揭示了它与所有其他结构特征核酸酶无关,并提供了 HUH 超家族成员的第一个视图。 Rep 与 SV40 T 抗原的起始结合域(Luo 等,1996)和牛乳头瘤病毒的复制起始蛋白 E1(Enemark 等,2000)同源。结合催化所需金属离子的 HUH 残基与带有两个活性位点酪氨酸残基的螺旋会聚,形成酶活性位点裂缝。随后 Rep 核酸酶结构域与代表 AAV 基因组两个特定区域的寡核苷酸的共晶结构表明,核酸酶结构域使用两种不同的蛋白质表面来识别其 DNA 靶标。一个表面结合位于病毒基因组最顶端的发夹,另一个表面识别靠近基因组末端的重复四核苷酸序列,该序列构成Rep结合位点。这些结构使我们能够提出一种六聚 Rep-DNA 复合物的组装模型,该复合物准备在病毒 DNA 上产生切口并开始将其解开,作为复制的前奏。位点特异性整合似乎也始于人类 19 号染色体相关序列上的切口。
尽管人们认为 Rep 组装为六聚体解旋酶,但以前从未观察到此类组装,并且 Rep 多聚化模式仍然存在争议。我们最近一直在研究 Rep 的 N 末端截短版本,其中核酸内切酶结构域缺失。 Rep 的这一部分在单链和 dsDNA 底物上组装为六聚体,并且不依赖于特定的病毒 DNA 序列或核苷酸的存在。 我们鉴定了负责 DNA 多聚化的蛋白质部分,并且我们已经能够使用电子显微镜直接可视化这些六聚体复合物。结晶试验正在进行中。
Enemark, E.J.、Chen, G.、Vaughn, D.E.、Stenlund, A. 和 Joshua-Tor, L. (2000) Mol。 6 号牢房,149-158。
弗洛特,T.R. (2005)儿科研究。 58、1143-1147。
Hickman, A.B.、Ronning, D.R.、Kotin, R.M. 和 Dyda, F. (2002) Mol。 10 号牢房,327-337。
Im, D.S. 和 Muzyczka, N. (1990) Cell 61, 447-457。
Le Bec, C. 和 Douar, A.M. (2006)吉恩·瑟尔。 13、805-813。
Lee, H.C.、Kim, S.J.、Kim, K.S.、Shin, H.CV. 和 Yoon, J. W. (2000) Nature 408, 483-488。
Luo, X.、Sanford, D.G.、Bullock, P.A. 和 Bachovchin, W.W. (1996) 国家。结构。生物。 3、1034-1039。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frederick Dyda其他文献
Frederick Dyda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frederick Dyda', 18)}}的其他基金
Structure and function of novel prokaryotic DNA transposases
新型原核DNA转座酶的结构和功能
- 批准号:
8741429 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Understanding the structural basis of replication initiation in AAV
了解 AAV 复制起始的结构基础
- 批准号:
9148791 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Structure and function of eukaryotic DNA transposases
真核DNA转座酶的结构和功能
- 批准号:
7734103 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Structure and function of eukaryotic DNA transposases
真核DNA转座酶的结构和功能
- 批准号:
10006695 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Structural biology of host factors affecting retroviral integration
影响逆转录病毒整合的宿主因素的结构生物学
- 批准号:
8148764 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Understanding the structural basis of replication initiation in AAV
了解 AAV 复制起始的结构基础
- 批准号:
8148763 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Understanding the structural basis of replication initiation in AAV
了解 AAV 复制起始的结构基础
- 批准号:
8349753 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Structure and function of novel prokaryotic DNA transposases
新型原核DNA转座酶的结构和功能
- 批准号:
8553460 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Understanding the structural basis of replication initiation in AAV
了解 AAV 复制起始的结构基础
- 批准号:
8553461 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
Structural biology of host factors affecting retroviral integration
影响逆转录病毒整合的宿主因素的结构生物学
- 批准号:
7593573 - 财政年份:
- 资助金额:
$ 40.52万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 40.52万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 40.52万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 40.52万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Operating Grants














{{item.name}}会员




